CD40LG and coronary artery disorder: Plasma levels of IgM against the IGKC2–19 unmodified peptide in CAD patients with a stenosis rate >70% were lower than HCs (p < 0.0001) and CAD patients with a stenosis rate <30% (p = 0.0056).